BOT 4.05% 38.5¢ botanix pharmaceuticals ltd

BOT - Anything but charting, page-8244

  1. 1,448 Posts.
    lightbulb Created with Sketch. 285
    Who thought that split was commercially astute? They are the reseller. We own the product. Peanuts. 70/30 split should have been agreed. All Kaken reports are doing is showing the demand. The financials aren't even worth mentioning.
    Last edited by Rorbag: 10/05/24
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.